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The p53 tumor suppressor belongs to a
gene family that includes p63 and p73
(Melino et al., 2003; Yang et al., 2002).
The three paralogs encode proteins with
remarkable similarity at the structural
and functional level. Each member of the
family functions as a sequence-specific
transcription factor, each member is
induced by different forms of stress
including DNA damage, and each mem-
ber has been implicated in pathways
leading to cell death. p63 and p73 are
more similar to each other than to p53,
and both can activate expression of
genes containing p53-responsive ele-
ments. Despite all these similarities, it
has become evident that these genes
are involved in different biological
processes and that they are not function-
ally redundant. One indication of this is
provided by the distinct patterns of
expression exhibited by the family mem-
bers. In contrast with the ubiquitous
expression of p53 mRNA, p63 is
expressed in the basal or progenitor lay-
ers of many epithelial tissues and p73 is
expressed in the epidermis, sinuses,
inner ear, and brain as well as in devel-
oping neurons. Another indication of
their individuality is provided by knockout
mouse studies. p63 null mice are born
with striking developmental malforma-
tions, including the lack of limbs and
epithelial structures. These mice die
within a day of birth due to desiccation
and maternal neglect. p73 null mice are
characterized by chronic infections and
developmental defects, including hip-
pocampal dysgenesis, hydrocephalus,
and abnormalities in the pheromone
sensory pathway. Both phenotypes are
very unlike that of p53 knockout mice,
which are without gross developmental
defects. Unlike p53 null mice, p73 null
mice do not develop tumors, and in con-
trast to p53, p73 and p63 are rarely
mutated in human cancers. While p63
and p73 can activate a subset of p53 tar-
get genes independently of p53, p63 and
p73 can also regulate specific sets of tar-
get genes. It is also notable that viral
oncoproteins such as SV40 large T anti-
gen, adenovirus E1B, and human papil-
loma virus E6, which bind and inactivate
p53 in order to promote cell cycle entry,
do not target p73 and p63. Altogether,
these data indicate that p53, p63, and
p73 have diverged significantly from a
common ancestral gene and that their
products have distinct nonoverlapping
functions.
In spite of these differences,
provocative findings suggest that func-
tional interactions—either collaborative
or inhibitory—can take place among
family members. Heterotypic interactions
are complicated by the multiple isoforms
of p63 and p73 that are expressed. The
p63 and p73 genes contain two separate
promoters that are used to generate
transcripts encoding proteins with
(TAp63 or TAp73) or without (∆Np63 or
∆Np73) an N-terminal transactivation
domain. Alternative splicing at the 3′ end
of the p63 and p73 RNA transcripts gen-
erates additional complexity by creating
both TA and ∆N proteins with different C
termini. The different isoforms appear to
act differently either in promoting or
repressing p53-dependent functions
including apoptosis. Perhaps the best
example of interference occurring in a
physiological setting was provided by
Pozniak et al. (2000), who demonstrated
that ∆Np73β was the predominant p73
isoform expressed in postnatal day 10
mouse brain and in sympathetic neu-
rons. In p73−/− mice, all isoforms of p73
are deleted, and p53-dependent apopto-
sis of developing neurons is greatly
enhanced. They concluded that ∆Np73β
plays a critical antiapoptotic function in
neurons by antagonizing p53-dependent
neuronal apoptosis.
An intriguing example of cooperation
amongst family members was provided
by Flores et al. (2002), who investigated
γ radiation-induced apoptosis in the
developing central nervous system of
embryos mutant for p53 family proteins.
p53 has been shown to be required for
radiation-induced apoptosis in the devel-
oping nervous system. Comparison of
wild-type, p53 null, p63 null, p73 null,
and doubly mutant p63/p73 null embryos
revealed that wild-type embryos were
radiation-sensitive, that the single
mutant p63−/− and p73−/− embryos were
partially resistant, and that the p63/p73
double null embryos were as resistant as
the p53−/− embryos.The authors conclud-
ed that p63 and p73 are required for p53-
dependent neuronal apoptosis in
irradiated embryos. The same study
reported a requirement for p73 and p63
in p53-dependent apoptosis in E1A-
expressing mouse embryo fibroblasts
(MEFs) treated with various genotoxic
agents, including doxorubicin, cisplatin,
and γ radiation. In addition, p63 and p73
were required for activation of certain
proapoptotic p53 target genes in the E1A
transformed MEFs. Chromatin immuno-
precipitation (ChIP) analyses indicated a
failure of p53 to bind proapoptotic pro-
moters in the absence of p63 and p73.
These data suggested that p63 and p73
may be required for the stable associa-
tion of p53 with a subset of its target pro-
moters and give rise to models involving
the assembly of transcriptional complex-
es containing all three family members
(reviewed in Urist and Prives, 2004).
A report by Senoo et al. (2004) in this
issue of Cancer Cell provides much-
needed clarity on the generality of the
concept that p53 requires p63 and p73
for its apoptotic function by showing that
at least in immature T cells, p53 func-
tions perfectly well on its own. Senoo et
al. (2004) used fetal hematopoietic (liver)
cells derived from wild-type, p73 null,
p63 null embryos or p63/p73 double null
embryos to reconstitute lymphocytes in
sublethally irradiated Rag2−/− mice. The
fetal liver cell adoptive transfer technique
is a widely accepted procedure to study
gene function in lymphocytes that avoids
any systemic defect imparted by loss or
aberrant expression of a gene. Any T or
B cells observed in Rag2−/− mice have
the genotype of the donor animal, since
Rag2−/− mice lack the V(D)J recombina-
tion machinery required for lymphocyte
maturation. Senoo et al. (2004) show that
overall numbers of lymphocytes in the
reconstituted thymi were similar, that the
proportion of CD4+, CD8+, double posi-
tive thymocytes were similar, and the
number and proportion of lymphocytes in
the spleen were similar. Importantly,
Rag2-reconstituted wild-type, p63 null,
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p73 null, and p63/p73 null thymocytes
were sensitive to irradiation in contrast to
p53 null thymocytes, which were resis-
tant. In addition, CD4+ purified mature T
cells derived from Rag2−/− mice having
single or combination losses of p63 and
p73 underwent apoptosis (activation-
induced cell death) following TCR stimu-
lation similar to that seen in wild-type
CD4+ T cells. Senoo et al. (2004) con-
clude that p63 and p73 are not required
for radiation-induced death in immature
T cells (a p53-dependent process) and
that p63 and p73 are also not required
for activation-induced cell death in
mature peripheral T cells (a p53-inde-
pendent process).
Senoo et al. (2004) claim that p53
can act independently of p63 and p73 in
apoptosis control, and their findings
challenge the notion that p63 and p73
largely mimic and facilitate the action of
p53. At least in immature thymocytes,
this certainly appears to be correct. In
the irradiated CNS of developing
embryos and in irradiated E1A-trans-
formed MEFs, however, p53 is depen-
dent on its sibling coactivators to
promote apoptosis. How does one begin
to explain these disparate findings?
The response of fibroblasts and
immature thymocytes to radiation-
induced damage is very different. Lowe
et al. (1993) showed clearly that early
passage p53+/+ and p53−/− MEFs do not
lose viability when treated with various
chemotherapeutic agents or γ radiation.
It is only after E1A is expressed that
these cells exhibit p53-dependent apop-
tosis. Hence, the requirement for p63
and p73 in E1A-transformed MEFs to
facilitate p53 function may be a require-
ment imposed by E1A expression.
Thymocytes, on the other hand, readily
undergo p53-dependent apoptosis in
response to irradiation in the absence of
E1A and require neither p63 nor p73.
Another possibility relates to cell
type specificity. Animal studies indicate
that p53-dependent apoptosis is restrict-
ed to certain tissues from irradiated mice
(spleen, thymus, small intestine, devel-
oping nervous system).This could reflect
tissue differences in DNA repair, p53
expression and activation, intracellular
death/survival pathways, or selective
transactivation/repression of p53 target
genes in different organs (Bouvard et al.,
2000; Fei et al., 2002). Promoter selectiv-
ity could reflect differences in the affinity
of various promoters for p53, such that
some are responsive only to high levels
of p53 or to certain modified forms of
p53. Promoter selectivity might also be
regulated by the interaction of p53 with
an ever-growing number of proteins that
act as transcriptional cofactors by selec-
tively stabilizing the interaction of p53
with specific promoters (Gudkov and
Komarova, 2003; Oren, 2003; Vousden
and Lu, 2002).
Future experiments will likely charac-
terize the p53-containing transcriptional
complexes that assemble on different
p53-responsive promoters in vivo in spe-
cific tissues and under specific stress
conditions. This will lead to a better
understanding of critical p53 modifica-
tions, transcriptional coactivators, and
obligatory histone modifications that are
involved in p53-dependent transcription-
al activity. The concept that ∆N-isoforms
of p63 and p73 antagonize p53 function
in different tissues needs to be investi-
gated more widely. In addition, future
experiments will continue to identify criti-
cal p53-dependent proapoptotic target
genes; these may be differentially regu-
lated in different cells and tissues with
correspondingly different coactivator
requirements. The different requirement
for p63 and p73 in p53-dependent apop-
tosis in neurons and thymocytes pro-
vides an entry point to investigate the
complexity of DNA damage responses in
the whole organism.
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